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Summary
. Survival of incident patients on RRT continued to
improve over the last 14 years for both short and
long term survival up to 10 years post RRT start.
. One year after 90 day age adjusted survival for
incident RRT patients in the 2013 cohort increased
to 91.4% from the previous year (91.0%); survival
increased in incident patients aged ,65 years and
in older patients (565 years).
. There was a difference in one year after 90 day
incident survival by age group and diabetic status:
diabetic patients aged ,65 years have slightly
worse survival than non-diabetic patients, but
survival for older diabetic patients (565 years)
was signiﬁcantly better than for non-diabetic
patients.
. One year age adjusted survival for prevalent dialysis
patients was 88.6% in the 2013 cohort, a slight
decrease from the 2012 cohort (89.3%). Age
adjusted one year survival for prevalent dialysis
patients with diabetic primary renal disease has
been declining slightly since 2012.
. Centre and UK country variability was evident in
incident and prevalent patient survival after adjust-
ing to age 60 and this ﬁnding would beneﬁt from
further investigation.
. The relative one year risk of death on RRT decreased
with age from about 19 times that of the general
population at age 35–39 years to 2.6 times at age
85 and over.
. In the prevalent RRT population, cardiovascular
disease was the most common cause of death,
accounting for 23% of deaths. Infection accounted
for 20% of deaths and treatment withdrawal for
16% of deaths.
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Introduction
The analyses presented in this chapter examine: a)
survival from the start of renal replacement therapy
(RRT) of adult patients; b) survival amongst prevalent
adult dialysis patients alive on 31st December 2013; c)
the death rate in the UK compared to the general popu-
lation; d) the causes of death for incident and prevalent
adult patients. They encompass the outcomes of the
total incident adult UK RRT population (2013) reported
to the UK Renal Registry (UKRR), including the 19.7%
who started on peritoneal dialysis and the 8.3% who
received a pre-emptive renal transplant. These results
are therefore a true reﬂection of the outcomes in the
whole UK adult incident RRT population. Analyses of
survival within the ﬁrst year of starting RRT include
patients who were recorded as having started RRT for
established renal failure (as opposed to acute kidney
injury) but who had died within the ﬁrst 90 days of start-
ing RRT, a group excluded from most other countries’
registry data. As is common in other countries, survival
analyses are also presented for the ﬁrst year after 90 days.
The term established renal failure (ERF) used through-
out this chapter is synonymous with the terms end stage
renal failure (ESRF) and end stage renal disease (ESRD)
which are in more widespread international usage.
Within the UK, patients have disliked the term ‘end
stage’; the term ERF was endorsed by the English
National Service Framework for Renal Services, pub-
lished in 2004.
Since 2006, the UKRR has openly reported and pub-
lished centre attributable RRT survival data. It is again
stressed that these are raw data which continue to require
very cautious interpretation. The UKRR can adjust for
the effects of the different age distributions of patients
in different centres, but lacks sufﬁcient data from many
participating centres to enable adjustment for primary
renal diagnosis, other comorbidities at start of RRT
(age and comorbidity, especially diabetes, are major fac-
tors associated with survival [1–3]) and ethnic origin,
which have been shown to have an impact on outcome
(for instance, better survival is expected in centres with
a higher proportion of Black and South Asian patients)
[4]. This lack of information on case-mix makes
interpretation of any apparent difference in survival
between centres and UK countries difﬁcult. Despite the
uncertainty about any apparent differences in outcome,
for centres which appear to be outliers the UKRR will
follow the clinical governance procedures as set out in
chapter 2 of the 2009 UKRR Report [5].
Methods
The unadjusted survival probabilities (with 95% conﬁdence
intervals) were calculated using the Kaplan–Meier method, in
which the probability of surviving more than a given time can
be estimated for all members of a cohort of patients overall or
by subgroup such as age group, but without any adjustment for
confounding factors such as age that affect the chances of survival.
Where centres are small, or the survival probabilities are greater
than 90%, the conﬁdence intervals are only approximate.
In order to estimate the difference in survival of different sub-
groups of patients within the cohort, a stratiﬁed proportional
hazards model (Cox) was used where appropriate. The results
from the Cox model were interpreted using a hazard ratio.
When comparing two groups, the hazard ratio is the ratio of the
estimated hazard for group A relative to group B, where the hazard
is the risk of dying at time t given that the individual has survived
until this time. The underlying assumption of a proportional
hazards model is that the hazard ratio remains constant through-
out the period under consideration. Whenever used, the assump-
tions of the proportional hazards model were tested by plotting the
log(−log(survival)) versus the log of survival time or by testing
time dependent covariates in the model.
To allow for comparisons between centres with differing age
distributions, survival analyses were statistically adjusted for age
and reported as survival adjusted to age 60. This gives an estimate
of what the survival would have been if all patients in that centre
had been aged 60 at the start of RRT. This age was chosen because
it was approximately the average age of patients starting RRT 15
years ago at the start of the UKRR’s data collection. The average
age of patients commencing RRT in the UK has recently stabilised
around an age of 62 years, but the UKRR has maintained age
adjustment to 60 years for comparability with all previous years’
analyses. Diabetic patients were included in all analyses unless
stated otherwise and for some analyses, diabetic and non-diabetic
patients were analysed separately and compared. Non-diabetic
patients were deﬁned as all patients excluding those patients
with diabetes as the primary renal disease. All analyses were
undertaken using SAS 9.3.
Centre variability for incident and prevalent patient survival
was analysed using a funnel plot. For any number of patients in
the incident or prevalent cohort (x-axis), one can identify whether
any given survival probability (y-axis) falls within, plus or minus
two standard deviations (SDs) from the national mean (solid
lines, 95% limits) or 3SDs (dotted lines, 99.9% limits).
Deﬁnition of RRT start date
The incident survival ﬁgures quoted in this chapter are from
the ﬁrst day of RRT whether with dialysis or a pre-emptive trans-
plant. In the UKRR all patients starting RRT for ERF are included
from the date of the ﬁrst RRT treatment wherever it took place (a
date currently deﬁned by the clinician) if the clinician considered
the renal failure irreversible. Should a patient recover renal
function within 90 days they were then excluded. These UK data
therefore may include some patients who died within 90 days
who had developed acute potentially reversible renal failure but
were recorded by the clinician as being in irreversible established
renal failure.
Previously, the UKRR asked clinicians to re-enter a code for
established renal failure in patients initially coded as having
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acute renal failure once it had become clear that there was no
recovery of kidney function. However, adherence to this require-
ment was very variable, with some clinicians entering a code for
established renal failure only once a decision had been made to
plan for long-term RRT [6]. All UK nephrologists have now
been asked to record the date of the ﬁrst haemodialysis session
and to record whether the patient was considered to have acute
kidney injury (acute renal failure) or to be in ERF at the time.
For patients initially categorised as ‘acute’, but who were sub-
sequently categorised as ERF, the UKRR assigns the date of this
ﬁrst ‘acute’ session as the date of start of RRT.
UKRR analyses of electronic data extracted for the immediate
month prior to the start date of RRT provided by clinicians high-
lighted additional inconsistencies in the deﬁnition of this ﬁrst
date when patients started on peritoneal dialysis, with the date
of start reported to the UKRR being later than the actual date of
start. These ﬁndings are described in detail in chapter 13 of the
2009 Report [6]. This concern is unlikely to be unique to the
UK, but will be common to analyses from all renal centres and
registries.
In addition to these problems of deﬁning day 0 within one
country, there is international variability when patient data are
collected by national registries with some countries (often for
ﬁnancial re-imbursement or administrative reasons) deﬁning the
90th day after starting RRT as day 0, whilst others collect data
only on those who have survived 90 days and report as zero the
number of patients dying within the ﬁrst 90 days.
Thus, as many other national registries do not include reports
on patients who do not survive the ﬁrst 90 days, survival from
90 days onwards is also reported to allow international compari-
sons. This distinction is important, as there is a much higher
death rate in the ﬁrst 90 days, which would distort comparisons.
Methodology for incident patient survival
The incident population is deﬁned as all patients over 18
who started RRT at UK renal centres. Patients were considered
‘incident’ at the time of their ﬁrst RRT, thus patients re-starting
dialysis after a failed transplant were not included in the incident
cohort (see appendix B:1 for a detailed deﬁnition of the incident
(take-on) population).
For incident survival analyses, patients newly transferred into a
centre who were already on RRT were excluded from the incident
population for that centre and were counted at the centre at which
they started RRT. Some patients recovered renal function after
more than 90 days but subsequently returned to RRT and for
these patients the most recent start of RRT was used.
The incident survival cohort was NOT censored at the time of
transplantation and therefore included the survival of the 8.3%
who received a pre-emptive transplant. An additional reason for
not censoring was to facilitate comparison between centres.
Centres with a high proportion of patients of South Asian and
Black origin are likely to have a healthier dialysis population,
because South Asian and Black patients are less likely to undergo
early transplantation [7], and centres with a high pre-emptive
transplant rate are likely to have a less healthy dialysis population
as transplantation selectively removes ﬁtter patients. However,
censoring at transplantation was performed in the 1997–2013
cohort to establish the effect on long term survival by age group
and also in the 2010–2013 cohort to investigate the effect on the
outlying status of centres.
The one year incident survival is for patients who started RRT
from 1st October 2012 until the 30th September 2013 and followed
up for one full year (e.g. patients starting RRT on 1st December
2012 were followed through to 30th November 2013). The 2014
incident patients could not be analysed as they had not yet been
followed for a sufﬁcient length of time. For analysis of one year
after 90 day survival, patients who started RRT from 1st October
2012 until 30th September 2013 were included in the cohort and
they were followed up for a full one year after the ﬁrst 90 days
of RRT.
Two years’ incident data (2012–2013) were combined to
increase the size of the patient cohort, so that any differences
between the four UK countries can be more reliably identiﬁed.
To help identify any centre differences in survival from the
small centres (where conﬁdence intervals are large), an analysis
of one year after 90 day survival using a rolling four year combined
incident cohort from 2010 to 2013 was also undertaken. A 10 year
rolling cohort was used when analysing trends over time and for
long term survival, a cohort from 1997 to 2013 was analysed.
The death rate per 1,000 patient years was calculated by divid-
ing the number of deaths by the person years exposed. Person
years exposed are the total years at risk for each patient (until
death, recovery or lost to follow up). The death rate is presented
by age group and UK nation.
Adjustment of one year after 90 day survival for the effect of
comorbidity was undertaken using a rolling four year combined
incident cohort from 2010 to 2013. Twenty-ﬁve centres returned
585% of comorbidity data for patients in the combined cohort.
Adjustment was ﬁrst performed to a mean age of 60 years, then
to the average distribution of primary diagnoses for the 25 centres.
The individual centre data were then further adjusted for average
distribution of comorbidity present at these centres.
Methodology for prevalent dialysis patient survival
The prevalent dialysis patient group was deﬁned as all patients
over 18 years old, alive and receiving dialysis on 31st December
2013 who had been on dialysis for at least 90 days at one of the
UK adult renal centres. Prevalent dialysis patients on 31st December
2013 were followed-up in 2014 and were censored at trans-
plantation. When a patient is censored at transplantation, this
means that the patient is considered as alive up to the point of
transplantation, but the patient’s status post-transplant is not
considered.
As discussed in previous reports, comparison of survival of
prevalent dialysis patients between centres is complex. Survival
of prevalent dialysis patients can be studied with or without
censoring at transplantation and it is common practice in some
registries to censor at transplantation. Censoring could cause
apparent differences in survival between those renal centres with
a high transplant rate and those with a low transplant rate,
especially in younger patients where the transplant rate is highest.
Censoring at transplantation systematically removes younger ﬁtter
patients from the survival data. The differences are likely to be
small due to the relatively small proportion of patients being trans-
planted in a given year compared to the whole dialysis population
(about 13% of the dialysis population aged under 65 and about 2%
of the population aged 65 years and over). To allow comparisons
with other registries the survival results for prevalent dialysis
patients CENSORED for transplantation have been quoted. To
understand survival of patients, including survival following
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transplantation, the incident patient analyses should be viewed.
The effect of not censoring at transplantation was performed in
the 2013 cohort to investigate the effect on the outlying status of
centres.
Methodology for comparing mortality in prevalent RRT
patients with the mortality in the general population
Data on the UK population in mid-2014 and the number of
deaths in each age group in 2014 were obtained from the Ofﬁce
of National Statistics. The age speciﬁc UK death rate was calcu-
lated as the number of deaths in the UK per thousand people in
the population. The age speciﬁc expected number of deaths in
the RRT population was calculated by applying the UK age speciﬁc
death rate to the total of years exposed for RRT patients in that age
group. This is expressed as deaths per 1,000 patient years. The age
speciﬁc number of RRT deaths is the actual number of deaths
observed in 2014 in RRT patients. The RRT observed death rate
was calculated as number of deaths observed in 2014 per 1,000
patient years exposed. Relative risk of death was calculated as
the ratio of the observed and expected death rates for RRT
patients. The death rate was calculated for the UK general popu-
lation by age group and compared with the same age group for
prevalent patients on RRT on 31st December 2013.
Methodology of causes of death
The EDTA-ERA Registry codes for causes of death were used.
These have been grouped into the following categories:
. Cardiac disease
. Cerebrovascular disease
. Infection
. Malignancy
. Treatment withdrawal
. Other
. Uncertain
Completeness of cause of death data was calculated for all
prevalent patients on RRT that died in a speciﬁc year with cause
of death data completed for that year. Patients that were lost to
follow up or that recovered were not included in the cause of
death completeness calculation.
Adult patients aged 18 years and over from England, Wales,
Scotland and Northern Ireland were included in the analyses of
cause of death. The incident patient analysis included all patients
starting RRT in the years 2000–2013. Analysis of prevalent
patients included all those aged over 18 years and receiving RRT
on 31st December 2013 and followed-up for one year in 2014.
Results
Incident (new RRT) patient survival
Overall survival
The 2013 incident cohort included 7,030 patients who
started RRT. Age adjusted (adjusted to age 60) one year
after 90 days survival for incident patients starting RRT
in 2013 (table 5.1), increased compared to last year:
91.4% compared to 91.0% in the 2012 cohort. Survival
at 90 days (adjusted to age 60) was also higher in the
2013 cohort at 96.9% (table 5.1) compared to 96.2% in
the 2012 cohort.
Survival by UK country
There was no evidence of a signiﬁcant difference in
survival at 90 days between the UK countries
(table 5.2), but there was evidence that one year after
90 day survival in Wales was lower compared to the
other UK countries (table 5.2). It has to be stressed that
the data has not been adjusted for differences in primary
renal diagnosis, ethnicity, socio-economic status or
comorbidity, nor for differences in life expectancy in
the general populations of the four UK countries. There
are known regional differences in the life expectancy of
the general population within the UK and these are likely
to be one of the reasons contributing to the variation in
survival between renal centres and UK countries.
Table 5.3 shows differences in life expectancy of the
Table 5.1. Survival of incident patients, 2013 cohort
Interval Unadjusted survival (%) Adjusted survival (%) 95% CI N
Survival at 90 day 94.9 96.9 96.4–97.4 7,030
Survival one year after 90 days 88.4 91.4 90.6–92.2 6,657
Table 5.2. Incident survival across the UK countries, combined two year cohort (2012–2013), adjusted to age 60
England N Ireland Scotland Wales UK
Survival at 90 day (%) 96.5 95.2 97.1 96.1 96.5
95% CI 96.1–96.9 93.5–97.0 96.2–98.0 95.0–97.2 96.1–96.9
Survival 1 year after 90 days (%) 91.5 91.9 90.6 86.5 91.2
95% CI 90.9–92.1 89.5–94.4 88.9–92.3 84.4–88.8 90.6–91.7
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general population between the UK countries for the
period 2012–2014.
Survival by modality
It is impossible to obtain truly valid comparisons of
survival of patients starting RRT on different treatment
modalities, as modality selection is not random. In the
UK, patients starting peritoneal dialysis as a group were
younger and ﬁtter and were transplanted more quickly
than those starting haemodialysis. The age adjusted one
year survival estimates for incident patients starting
RRT on haemodialysis (HD) and peritoneal dialysis
(PD) were 89.8% and 93.4% respectively, with HD patient
survival increasing by 0.6% from the previous year
(ﬁgure 5.1). Over the last 10 years the one year after 90
days survival has progressively improved in HD patients,
but in PD patients survival has remained static over the
last ﬁve years (ﬁgure 5.1).
Survival by age
Tables 5.4 and 5.5 show survival for all incident
patients, those aged 565 years and those aged ,65
years. Both short term (survival at 90 days) and one
year after 90 days survival increased marginally: survival
at 90 days increased to 94.9% compared to 94.5% in the
previous year (2012 cohort) and one year after 90 days
survival increased to 88.4% compared to 88.0% in the
2012 cohort. There was a steep decline in survival with
advancing age (ﬁgures 5.2 and 5.3). There was evidence
that one year after 90 days survival in the 85+ age
group increased signiﬁcantly from 66.2% in the 2012
cohort to 73.2% in the 2013 cohort.
There was a curvilinear increase in the death rate per
1,000 patient years with age for the period one year
after 90 days (ﬁgure 5.3). There was evidence that the
overall death rate in Wales was higher than in the other
UK countries, mostly due to a higher death rate in
Wales for older patients (565 years old) (ﬁgure 5.3). A
similar ﬁnding is reported in table 5.12, where there
was evidence that the one year death rate in prevalent
dialysis patients (2013 cohort) was higher in Wales com-
pared to England. Results in table 5.2 also conﬁrm a
Table 5.3. Life expectancy in years in the UK countries, 2012–
2014 (source ONS [8])
At birth At age 65
Country Male Female Male Female
England 79.4 83.1 18.6 21.1
Northern Ireland 78.3 82.3 18.1 20.5
Scotland 77.1 81.1 17.3 19.6
Wales 78.4 82.3 18.0 20.5
UK 79.1 82.8 18.4 20.9
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transplantation)
Table 5.4. Unadjusted 90 day survival of incident patients,
2013 cohort, by age
Age group Survival (%) 95% CI N
18–64 98.1 97.6–98.5 3,585
565 91.6 90.7–92.5 3,445
All ages 94.9 94.4–95.4 7,030
Table 5.5. Unadjusted one year after day 90 survival of incident
patients, 2013 cohort, by age
Age group Survival (%) 95% CI N
18–64 94.2 93.3–94.9 3,506
565 81.9 80.5–83.2 3,151
All ages 88.4 87.6–89.1 6,657
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signiﬁcantly higher death rate at one year after 90 days in
Wales compared to the other UK countries (table 5.2).
From ﬁgure 5.4 it can be seen that 50% of patients
starting RRT aged between 45–54 survived for over 10
years, 50% of patients starting RRT aged between 55–
64 survived for about 5.9 years and 50% of patients
starting RRT aged between 65–74 survived for about
3.4 years.
Figure 5.5 illustrates the survival of incident patients,
excluding those who died within the ﬁrst 90 days and
shows that 50% of patients aged between 55–64 years
survived for six years and 50% of patients aged between
65–74 years survived for about 3.7 years. These survival
results are similar to those that included the ﬁrst 90
days (ﬁgure 5.4).
Censoring at transplantation would make the longer
term outcomes of younger patients (who were more likely
to have undergone transplantation) appear worse than
they actually were. Without censoring, the 10 year survi-
val for patients aged 18–34 years was 83.7% (ﬁgure 5.4),
which contrasts sharply with a 58.3% survival when cen-
soring at the time of transplantation (data not shown).
The 10 year survival without and with censoring at trans-
plantation were 70.7% and 44.8% for age group 35–44
and 54.7% and 31.1% for age group 45–54 respectively.
This difference in survival is less pronounced in older
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age groups, especially for patients aged 65+. For more
detailed information on this effect, refer to the 2008
Report [9].
Age and the hazard of death
Figure 5.6 shows the monthly hazard of death from the
ﬁrst day of starting RRT by age group, which falls sharply
during the ﬁrst 4–5 months, particularly for older
patients (565 years), after which time the hazard
remains relatively stable up to one year.
The 10 year hazard of death at 90 days increased to
1.85 in the 2013 cohort from 1.68 (2012 cohort) whereas
the hazard in the 1st year after 90 days was similar. A 10
year increase in patient age was associated with a 1.85
times increased risk of death within 90 days and a 1.65
times increased risk of death within one year after 90
days (table 5.6).
Survival by gender
There were no survival differences between genders in
an incident cohort of patients starting RRT from 2002 to
2011 and followed up for a minimum of three years until
2014 (ﬁgure 5.7). There was also no evidence of a survival
difference between genders in the ﬁrst 90 days and one
year after the ﬁrst 90 days (data not shown).
Survival in the 2004–2013 cohort
The death rate per 1,000 patient years in the ﬁrst year
of starting RRT from 2004 to 2013 is shown in ﬁgure 5.8.
There was a declining trend in the overall death rate with
a steeper rate of decline in the older age group (565
years). It is important to note that these death rates are
not directly comparable with those produced by the
USRDS Registry, as the UK data include the ﬁrst 90 day
period when death rates are higher than subsequent time
periods.
The time trend changes in one year after 90 days
incident survival over the period 2004–2013 are shown
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Table 5.6. Increase in proportional hazard of death for each 10
year increase in age, 2013 incident cohort
Interval
Hazard of death for
10 year age increase 95% CI
First 90 days 1.85 1.68–2.03
1 year after ﬁrst 90 days 1.65 1.56–1.75
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in ﬁgure 5.9. The left hand plot, which includes only those
centres that have been sending data continuously since
2000, shows a similar improvement in survival to the
plot in which data from all renal centres were analysed.
One year after 90 days incident patient survival in the
2004–2013 cohort by centre, UK country and overall, can
be found in appendix 1, table 5.22.
Long term survival: trends up to 10 years post RRT
start
Longer term survival from start of RRT continued to
improve for incident patients (tables 5.7 and 5.8). There
was a steep decline in survival with advancing age. The
unadjusted survival analyses (tables 5.7, 5.8 and
ﬁgures 5.10, 5.11) show a large improvement in one to
10 year survival across the years for both those aged
under and those 65 years and over. One year survival
amongst patients aged ,65 years at start of RRT has
improved from 87.5% in the 1998 cohort to 93.7% in
the 2013 cohort.
Although survival has improved both in patients aged
under 65 and those aged 565 years, the improvement
was more pronounced in patients aged 565: there has
been a 15.8% absolute improvement in one year survival
from the 1998 to 2013 cohorts (table 5.8). As these are
observational data it remains difﬁcult to attribute this
reduction in risk of death to any speciﬁc improvements
in care.
Change in survival on RRT by vintage
Figure 5.12 shows the six monthly hazard of death by
age group for incident patients. There is little evidence of
a worsening prognosis with time on RRT (vintage) for the
majority of incident RRT patients in the UK (not cen-
sored for transplantation), although an increased hazard
over time is evident for incident patients aged 65 years
and older. When censoring for transplantation an
apparent vintage effect is evident (data not shown) and
this effect is at least in part because younger and healthier
patients are only included in the survival calculation up to
the date of transplantation. In the older age groups
there were decreasing numbers remaining alive beyond
seven years accounting for the increased variability seen.
Figures 5.13 and 5.14 show these data for the non-diabetic
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Table 5.7. Unadjusted survival of incident patients, 1998–2013 cohort for patients aged 18–64 years
Cohort 1 year 2 year 3 year 4 year 5 year 6 year 7 year 8 year 9 year 10 year
95% CI for
latest year N
2013 93.7 92.9–94.5 3,585
2012 93.1 87.3 86.2–88.4 3,542
2011 93.4 88.7 83.7 82.4–84.9 3,356
2010 92.2 86.6 81.7 77.3 75.8–78.7 3,365
2009 91.3 85.0 80.4 76.3 71.1 69.5–72.6 3,389
2008 91.5 86.0 81.1 76.9 73.2 69.5 67.9–71.0 3,445
2007 92.6 87.1 81.8 76.9 73.1 69.5 66.1 64.4–67.7 3,328
2006 90.6 85.0 80.1 75.7 72.0 68.1 64.1 61.3 59.5–63.0 3,160
2005 89.6 83.6 78.6 73.9 69.3 65.7 62.5 59.5 56.5 54.7–58.3 2,830
2004 89.6 83.4 78.0 72.6 67.9 64.2 61.0 57.2 54.6 53.0 51.1–55.0 2,563
2003 89.4 82.7 77.3 72.3 67.3 63.2 59.5 56.7 54.1 51.6 49.5–53.6 2,265
2002 88.5 80.7 74.7 69.1 65.0 61.1 57.7 54.8 51.6 49.5 47.3–51.7 2,023
2001 88.0 81.0 75.4 70.3 65.3 60.6 56.6 53.1 50.2 48.0 45.7–50.4 1,739
2000 89.1 81.3 74.5 69.1 63.6 59.0 55.5 52.3 49.9 47.2 44.6–49.7 1,528
1999 87.0 81.1 73.3 67.5 62.1 58.1 53.9 51.0 48.5 46.9 44.2–49.6 1,346
1998 87.5 80.2 74.4 69.5 64.1 59.1 55.1 53.1 49.9 47.7 44.7–50.5 1,166
Table 5.8. Unadjusted survival of incident patients, 1998–2013 cohort for patients aged 565 years
Cohort 1 year 2 year 3 year 4 year 5 year 6 year 7 year 8 year 9 year 10 year
95% CI for
latest year N
2013 78.5 77.1–79.9 3,445
2012 77.3 65.3 63.6–66.9 3,334
2011 77.4 62.8 51.4 49.7–53.1 3,365
2010 76.3 63.4 51.2 41.9 40.2–43.6 3,277
2009 76.6 63.3 52.5 41.6 32.9 31.3–34.5 3,371
2008 74.6 61.2 49.9 40.5 32.3 25.8 24.2–27.3 3,175
2007 75.1 61.2 49.8 40.5 32.0 25.5 20.2 18.8–21.6 3,209
2006 72.0 58.2 46.9 37.2 29.0 23.2 17.7 13.5 12.3–14.7 3,120
2005 71.0 57.2 45.2 36.1 27.8 21.1 16.6 12.5 9.9 8.9–11.0 2,936
2004 68.9 53.9 42.4 33.9 26.8 20.9 16.3 12.9 9.9 7.6 6.7–8.7 2,628
2003 68.4 53.6 41.7 31.8 24.3 18.1 14.2 11.1 8.5 6.8 5.8–7.9 2,315
2002 66.0 50.7 40.3 31.8 23.9 18.3 13.7 10.9 8.2 6.5 5.5–7.6 2,086
2001 66.5 51.8 38.4 28.8 21.8 16.0 12.0 9.1 7.2 5.5 4.5–6.7 1,709
2000 66.0 52.3 39.5 28.5 22.2 17.2 13.1 9.7 7.5 5.7 4.6–6.9 1,496
1999 68.4 51.6 39.1 29.8 22.2 16.2 11.5 8.4 6.2 4.9 3.8–6.2 1,213
1998 62.7 45.5 36.2 26.5 20.1 14.0 10.6 7.6 5.7 4.6 3.5–6.1 1,016
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and diabetic patients respectively. An increased hazard of
death over time is evident for diabetic patients pre-
dominantly over .65 years of age.
Centre variability in one year after 90 days survival
Centre variability was assessed in a larger cohort across
several years due to small numbers of patients and wide
conﬁdence intervals (appendix 1, table 5.22) in the 2013
incident cohort. Similar to previous years, sustained per-
formance was assessed in a rolling four year cohort from
2010 to 2013. These data are presented as a funnel plot in
ﬁgure 5.15. Table 5.9 allows centres to be identiﬁed on
this graph by ﬁnding the number of patients treated by
the centre and then looking up this number on the x-
axis. One centre (Swansea) had survival below the 95%
lower limit whilst ﬁve centres (London St. George’s,
London Guy’s, Western Trust Northern Ireland, Reading,
Exeter) had survival above the 95% upper limit and this is
an increase from the previous cohort where four centres
were survival outliers above the 95% upper limit.
With 71 centres it would be expected that only three
centres would be outside these limits by chance. It is
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important to acknowledge that these data have not been
adjusted for any patient related factor except age (i.e. not
comorbidity, primary renal disease or ethnicity) and have
not been censored at transplantation, so the effect of
differing centre rates of transplantation was not taken
into account. Figure 5.16 illustrates the effect of adjusting
for comorbidity on survival in centres with good comor-
bidity returns (585%), with the biggest improvement in
survival seen in Swansea. Adjustment for comorbidity
could have an important effect in some renal centres
like Swansea that seem to have a higher comorbid burden
in their RRT population and this could affect the outlier
status of centres as illustrated in ﬁgure 5.15, but due to
poor comorbidity returns for many renal centres, comor-
bidity adjustment for the entire incident RRT population
is not yet possible. Case mix adjustment performed in a
cohort of incident patients starting RRT in England
from 2002 to 2006 and linked to the Hospital Episodes
Statistics (HES) data, found that three of the four survival
outliers were no longer outliers after adjustment for HES-
derived case mix. Swansea could not be evaluated in this
analysis as the linkage was only done for England’s RRT
patients, but the study results highlight that variability in
survival between centres is affected by case mix [10].
Also see appendix 1, table 5.22 and 5.23 for unadjusted
and adjusted survival together with 95% conﬁdence inter-
vals for incident patient survival one year after 90 days
and at 90 days. Table 5.24 in appendix 1 shows the one
year after 90 day incident survival by centre for incident
cohort years 2004–2013, adjusted to age 60. One to ﬁve
year survival after the ﬁrst 90 days of RRT adjusted to
age 60 is included in appendix 1, table 5.25 for incident
cohorts 2009–2013 and is a new table in the survival
chapter.
Centre variability in one year after 90 day survival:
impact of adjustment for comorbidity
Although comorbidity returns to the UKRR have
remained poor, there was an increase in the number of
centres (26 to 31 centres) returning585% of comorbidity
data to the UKRR for patients starting RRT in 2013. These
analyses use a different cohort, a combined incident cohort
from 2010–2013 where 25 centres returned comorbidity
data over the period for 585% of patients and these
centres were included in this analysis. Adjustment was
ﬁrst performed to age 60, then to the average distribution
of primary renal diagnoses for the 25 centres. Further
adjustment was then made to the average distribution
of comorbidities present at those centres (table 5.10).
It can be seen that adjustment for age has the largest
effect, most notably in those centres with the lower
unadjusted survival ﬁgures. Survival improved for all
centres after adjustment for age, as the average age for
incident patients was higher than the adjustment to the
average age of 60 years. There were only minor differ-
ences for most centres after adjustment for primary
renal diagnosis, but survival increased by 51% for two
centres (Swansea, Newry). In ﬁve centres (Swansea,
Newry, Basildon, Bradford, Leeds) adjustment for
comorbidity had a noticeable effect (51% increase) on
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Fig. 5.14. Six monthly hazard of death, by
vintage and age group, 1997–2013 diabetic
incident cohort after day 90 (not censored at
transplantation)
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adjusted survival (table 5.10, ﬁgure 5.16) helping to
explain the lower survival noted in ﬁgure 5.15. After
adjustment for age, primary renal diagnosis and comor-
bidity, Swansea, Ulster and Wrexham had a noticeable
improvement in survival of 9.4%, 7.7% and 7.0%
respectively.
Survival in patients with diabetes
Although it has previously been shown that diabetic
patients have worse long term survival compared to
non-diabetic patients [3], non-diabetic patient survival
in the older age group (565 years) was worse compared
to diabetic patients in the same age group during the ﬁrst
90 days of starting RRT (2013 cohort) (ﬁgure 5.17) and in
the subsequent year (ﬁgure 5.18); this might be due to
patient selection. Survival in patients ,65 years was
almost similar between diabetic and non-diabetic patients
during the ﬁrst 90 days of starting RRT and in the sub-
sequent year.
Long term survival for diabetic and non-diabetic
patients was evaluated in a cohort of patients starting
RRT from 2002 to 2011 with a minimum of three years
Table 5.9. Age adjusted (to age 60) one year after 90 day survival, 2010–2013 incident cohort
1 year after 90 days
Limits for funnel plot
Centre N
Adjusted
survival %
Lower
95% limit
Upper
95% limit
D & Gall 44 90.2 77.9 96.4
Clwyd 74 90.0 81.7 95.5
Inverns 77 94.9 81.9 95.5
Bangor 89 90.4 82.7 95.2
Newry 95 87.6 83.0 95.1
Ulster 99 89.7 83.2 95.1
Carlis 106 91.4 83.5 95.0
Antrim 109 87.6 83.7 94.9
West NI 112 95.5 83.8 94.9
Wrexm 113 86.5 83.8 94.9
Sthend 117 91.4 84.0 94.8
Colchr 125 88.6 84.2 94.7
Klmarnk 141 88.2 84.7 94.5
Ipswi 142 92.1 84.7 94.5
Krkcldy 147 90.8 84.8 94.5
Basldn 153 89.6 85.0 94.4
York 166 90.5 85.3 94.3
Donc 168 90.9 85.3 94.3
Chelms 171 88.1 85.4 94.2
Truro 172 93.4 85.4 94.2
Dudley 181 91.4 85.5 94.2
Dundee 183 91.1 85.6 94.2
Abrdn 196 92.2 85.8 94.1
Liv Ain 199 89.6 85.8 94.0
Shrew 206 87.8 85.9 94.0
Wirral 210 90.2 86.0 94.0
Airdrie 217 88.9 86.1 93.9
Plymth 224 93.0 86.2 93.9
Sund 224 88.9 86.2 93.9
Glouc 231 92.3 86.2 93.8
Bradfd 234 89.6 86.3 93.8
Dorset 274 89.8 86.7 93.6
Edinb 277 88.2 86.7 93.6
Derby 286 89.6 86.8 93.6
Belfast 288 91.6 86.8 93.6
Norwch 293 89.4 86.8 93.5
1 year after 90 days
Limits for funnel plot
Centre N
Adjusted
survival %
Lower
95% limit
Upper
95% limit
L St.G 318 93.9 87.0 93.5
Wolve 326 87.6 87.1 93.4
Stoke 335 90.3 87.1 93.4
Newc 347 88.4 87.2 93.4
Redng 356 93.8 87.2 93.3
Hull 360 90.9 87.3 93.3
Liv Roy 365 89.6 87.3 93.3
B Heart 378 91.7 87.4 93.3
Covnt 391 89.5 87.4 93.2
Middlbr 399 89.7 87.5 93.2
Nottm 419 92.4 87.5 93.1
Camb 460 92.0 87.7 93.1
Stevng 465 91.9 87.7 93.0
Swanse 465 85.3 87.7 93.0
Exeter 469 93.1 87.7 93.0
Brightn 477 89.3 87.8 93.0
Kent 477 91.1 87.8 93.0
Salford 503 89.2 87.9 93.0
L Guys 525 93.7 87.9 92.9
Prestn 531 91.7 87.9 92.9
Sheff 534 91.2 87.9 92.9
L Kings 541 90.1 88.0 92.9
Leeds 573 91.0 88.1 92.8
Bristol 598 90.7 88.1 92.8
Ports 629 90.5 88.2 92.8
Oxford 639 91.7 88.2 92.7
M RI 640 90.6 88.2 92.7
Glasgw 650 88.9 88.2 92.7
Cardff 684 88.4 88.3 92.7
B QEH 813 91.4 88.5 92.5
Carsh 830 91.9 88.5 92.5
L Rfree 837 91.6 88.6 92.5
Leic 937 91.0 88.7 92.4
L Barts 944 91.8 88.7 92.4
L West 1352 91.4 89.1 92.2
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Fig. 5.16. The effect on survival after sequential adjustment for age, primary renal diagnosis and comorbidity, 2010–2013 incident
cohort
Table 5.10. The effect of adjustment for age, primary renal diagnosis and comorbidity on survival, 2010–2013 incident cohort, %
survival one year after 90 days
Centre∗ Unadjusted Age adjusted Age, PRD adjusted
Age, PRD and
comorbidity adjusted
Swanse 79.8 86.5 87.9 89.3
Wrexm 80.0 86.6 87.4 87.0
Ulster 82.5 89.5 90.1 90.2
Antrim 83.2 88.6 89.0 89.4
Bangor 83.5 88.7 89.2 88.8
Newry 83.7 87.4 88.8 89.9
Wolve 83.9 87.6 88.5 88.0
Dorset 84.9 90.5 90.6 91.2
Basldn 85.5 89.8 89.7 90.8
Middlbr 87.0 90.1 90.9 91.6
Kent 87.3 91.1 91.6 90.9
L Kings 87.4 90.1 90.4 90.8
Bradfd 87.7 89.6 89.9 90.9
Bristol 88.3 91.8 92.1 92.9
Derby 88.3 91.2 91.9 92.1
Sund 88.4 90.3 90.9 91.0
Leeds 88.5 90.9 91.1 92.1
York 89.0 91.4 91.7 91.9
Hull 89.4 92.0 92.3 92.7
Nottm 89.5 92.4 92.9 93.0
Oxford 89.6 91.7 92.0 92.2
Sthend 89.7 93.7 93.9 93.8
B Heart 90.7 93.3 93.9 94.0
Exeter 92.5 95.4 95.6 95.6
B QEH 96.2 97.0 97.2 97.1
All 25 centres 88.2 91.4 91.9 92.2
PRD primary renal diagnosis
∗Centre included if 585% comorbidity data available
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follow up until 2014. These data show large differences
between diabetic and non-diabetic patient survival in
the age groups 18–44 and 45–64 years. In age group
18–44, 89% of non-diabetic patients were alive ﬁve
years after start of RRT compared to 71% for diabetic
patients. In the age group 45–64, 68% of non-diabetic
patients were alive ﬁve years after start of RRT compared
to 51% for diabetic patients (ﬁgure 5.19). The initial sur-
vival difference where non-diabetic incident patients in
the older age group (565 years) have worse survival
than incident diabetic patients in the same age group,
diminished over the years until there was very little differ-
ence in ﬁve year survival between these patients.
Survival in prevalent dialysis patients
Overall survival
Table 5.11 shows the one year survival for prevalent
patients on dialysis. One year age adjusted survival for
prevalent dialysis patients decreased to 88.6% in the
2013 cohort compared to 89.3% in the 2012 cohort.
Survival by UK country
The one year death rate for prevalent dialysis patients
in each UK country is shown in table 5.12 for the 2013
cohort and survival increased across all four UK nations
compared to the previous year (2012 cohort). There was
evidence that the one year death rate inWales was signiﬁ-
cantly higher than in England: the higher median age in
Wales compared to England and socio-economic factors
such as life expectancy of the population and area depri-
vation, would affect the death rate in Wales. These results
are unadjusted for age, primary renal diagnosis or
comorbidity.
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Fig. 5.19. Long term survival for incident diabetic and non-
diabetic patients by age group, 2002–2011 cohort, followed up
for a minimum of three years
Table 5.11. One year survival of prevalent dialysis patients in the UK (unadjusted unless indicated otherwise)
Patient group Patients Deaths Survival 95% CI
Dialysis patients 2013 cohort
All 26,184 3,770 85.0 84.5–85.4
All – adjusted to age 60 26,184 3,770 88.6 88.2–89.1
2 year survival – dialysis patients
All patients alive on 31/12/2012 26,060 6,667 72.1 71.5–72.6
Cohorts of patients alive on 31/12/2013 unless indicated otherwise
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One year survival of prevalent dialysis patients by
centre
The age adjusted (adjusted to age 60) one year survival
of dialysis patients by centre is illustrated in a funnel plot
(ﬁgure 5.20). With 71 centres included in the analyses, it
would be expected by chance that three centres would fall
outside the 95% (1 in 20) conﬁdence limits. The survival
for one centre (Portsmouth) was below the 95% conﬁ-
dence limit, and for three centres (London St George’s,
Dorset, Stevenage) above the 95% conﬁdence limits.
Case mix adjustment performed in a cohort of incident
patients starting RRT in England from 2002 to 2006 and
linked to the Hospital Episodes Statistics (HES) data,
showed that the lower than expected survival in Ports-
mouth may be explained by case mix [10]. This study
found that three of the four survival outliers were no
longer outliers after adjustment for HES-derived case
mix. It is not yet possible to routinely perform this adjust-
ment using HES-linked data, but looking back at the
2002–2006 HES-linked data, there was a large improve-
ment in survival at Portsmouth after case mix adjustment
and the current outlier status at this centre may reﬂect a
higher comorbid burden in prevalent dialysis patients at
this centre.
The funnel plot analysis shows a decrease in the
number of centres that were outliers below the 95%
lower limits compared to last year (2012 cohort) when
there were four outlying centres. The number of centres
that were outliers above the 95% upper limit was the
same as in the previous year (2012 cohort). Not censoring
at transplantation did not change the results of the out-
lying centres.
Table 5.13 allows centres in ﬁgure 5.20 to be identiﬁed
by ﬁnding the number of patients treated by the centre
and the corresponding survival and then looking this
up on the axes of the funnel plot.
One year survival of dialysis patients by centre is illus-
trated in ﬁgures 5.21 and 5.22 for patients aged,65 years
and those aged 565 years.
Survival by age group
Figure 5.23 shows the one year survival of prevalent
dialysis patients who were alive and receiving dialysis
on 31st December 2013, stratiﬁed by age group. There
was a curvilinear decrease in survival with increasing
age (ﬁgure 5.23).
One year death rate in prevalent dialysis patients in
the 2013 cohort by age group
The death rates for prevalent patients on dialysis by
age group are shown in ﬁgure 5.24. The younger patients
included in this analysis are a selected higher risk group,
as the similar aged transplanted patients have been
excluded. The increase in the death rate was not linear
with age; in younger patients (,55 years of age) a 10
year increase in age increased the death rate by about
25 deaths per 1,000 patient years compared with an
increase of 88 deaths per 1,000 patient years in older
patients (75+). There was evidence that the death rate in
Wales was signiﬁcantly higher compared to England, but
there was no evidence that the apparent difference in the
death rates between other UK countries were signiﬁcant.
Time trends in survival, 2004 to 2013
Figure 5.25 illustrates that one year survival for preva-
lent dialysis patients in England gradually improved from
2004 to 2011 with a gradual decrease thereafter. In
Northern Ireland and Wales the numbers of patients
were much smaller than in England and survival was
therefore more variable with very wide conﬁdence inter-
vals, making it difﬁcult to draw conclusions on trends.
The change in prevalent survival by centre over the cohort
years 2004 to 2013 is included in appendix 1, table 5.26.
Survival in patients with diabetes
There was a large difference (8.3%) in one year survival
in younger (aged ,65 years) prevalent dialysis patients
without diabetes compared to patients with diabetes,
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Fig. 5.20. One year survival funnel plot of prevalent dialysis
patients by centre adjusted to age 60, 2013 cohort
Table 5.12. One year death rate per 1,000 prevalent dialysis
patient years in the 2013 cohort and median age of prevalent
dialysis patients by country
England N Ireland Scotland Wales
Death rate 159 180 177 200
95% CI 154–165 149–216 158–199 174–229
Median age 66.6 68.9 65.9 68.6
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whereas survival was very similar for non-diabetic com-
pared with diabetic older (aged 65+ years) prevalent
dialysis patients (2.4% difference, table 5.14). Similar
ﬁndings were reported for incident RRT patients (see
ﬁgures 5.17 to 5.19 and discussion).
Time trends in patients with a primary diagnosis of
diabetes
The age adjusted one year survival for prevalent
dialysis patients with diabetic primary renal disease in
the UK are shown in table 5.15. The proportion of preva-
lent dialysis patients with diabetes surviving one year has
been variable over the last ten years and has decreased
slightly since 2012.
Death rate on RRT compared with the UK general
population
The death rate of patients on RRT compared to the
general population is shown in table 5.16. The relative
risk of death on RRT decreased with age from a peak of
more than 30 times that of the general population at
Table 5.13. One year survival of prevalent dialysis patients in each centre (adjusted to age 60), 2013 cohort
Limits for funnel plot
Centre N
Adjusted
survival %
Lower
95% limit
Upper
95% limit
D & Gall 57 86.4 77.5 94.6
Inverns 80 88.7 79.6 94.0
Carlis 85 88.3 80.0 93.8
Clwyd 89 88.8 80.2 93.7
Bangor 95 85.6 80.5 93.6
Newry 104 90.6 81.0 93.5
Colchr 111 88.4 81.3 93.3
Ulster 115 91.3 81.4 93.3
Wrexm 121 88.0 81.6 93.2
Sthend 129 90.3 81.9 93.1
Antrim 134 85.3 82.1 93.0
Chelms 139 90.5 82.2 92.9
West NI 141 85.7 82.2 92.9
Ipswi 143 89.7 82.3 92.9
York 155 88.2 82.6 92.8
Truro 160 90.1 82.7 92.7
Liv Ain 161 87.6 82.7 92.7
Plymth 162 86.9 82.8 92.7
Krkcldy 163 84.2 82.8 92.7
Klmarnk 167 91.8 82.9 92.6
Dundee 182 90.4 83.1 92.5
Donc 184 90.4 83.2 92.5
Airdrie 192 85.7 83.3 92.4
Basldn 194 86.4 83.3 92.4
Sund 194 88.1 83.3 92.4
Shrew 201 86.4 83.4 92.3
Bradfd 216 87.5 83.7 92.2
Dudley 217 87.4 83.7 92.2
Glouc 227 92.1 83.8 92.2
Abrdn 229 84.1 83.8 92.1
Wirral 236 84.5 83.9 92.1
Belfast 245 89.2 84.0 92.0
Edinb 285 87.4 84.4 91.8
Derby 299 90.1 84.5 91.8
Newc 303 86.4 84.5 91.7
Dorset 310 92.2 84.6 91.7
Limits for funnel plot
Centre N
Adjusted
survival %
Lower
95% limit
Upper
95% limit
L St.G 322 92.2 84.7 91.7
Redng 326 89.5 84.7 91.6
Middlbr 335 85.3 84.8 91.6
Norwch 351 88.8 84.9 91.6
Wolve 367 89.9 85.0 91.5
Swanse 373 87.2 85.0 91.5
Stoke 376 88.8 85.0 91.5
Hull 384 87.6 85.0 91.4
Liv Roy 436 87.0 85.3 91.3
Kent 437 87.8 85.3 91.3
Covnt 442 86.1 85.3 91.3
B Heart 442 87.5 85.3 91.3
Salford 444 89.0 85.3 91.3
Nottm 445 88.5 85.3 91.3
Exeter 456 90.1 85.4 91.2
Brightn 461 87.2 85.4 91.2
Camb 463 87.7 85.4 91.2
Oxford 520 87.5 85.6 91.1
Cardff 539 86.6 85.7 91.0
Leeds 543 88.7 85.7 91.0
Stevng 554 92.0 85.7 91.0
Bristol 561 89.2 85.7 91.0
M RI 561 86.3 85.7 91.0
L Kings 565 90.4 85.7 91.0
Prestn 573 88.7 85.8 91.0
Glasgw 611 87.8 85.9 90.9
Sheff 626 88.2 85.9 90.9
Ports 631 85.7 85.9 90.9
L Guys 633 90.5 85.9 90.9
L Rfree 801 90.0 86.2 90.6
Carsh 840 89.6 86.3 90.6
Leic 987 89.3 86.5 90.5
B QEH 1,031 89.6 86.5 90.4
L Barts 1,082 90.3 86.6 90.4
L West 1,441 90.0 86.9 90.2
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age 25–29 years to 2.6 times the general population at age
85 and over. Figure 5.26 shows that the relative risk of
death has decreased substantially for the younger age
groups (,50 years) whereas the relative risk of death in
patients aged over 55 has not changed greatly compared
to the relative risk of death in the 1998–2001 cohort. The
overall relative risk of death at 6.2 in the 2013 cohort was
similar to the death rate in the last three years (2012, 2011
and 2010 cohorts).
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Fig. 5.21. One year survival of prevalent dialysis patients aged under 65 by centre, 2013 cohort
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Fig. 5.22. One year survival of prevalent dialysis patients aged 65 years and over by centre, 2013 cohort
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Fig. 5.23. One year survival of prevalent dialysis patients by age
group, 2013 cohort
18–34 35–44 45–54 55–64 65–74 75–84 85+
Age group
0
100
200
300
400
500
600
D
ea
th
 ra
te
England
N Ireland
Scotland
Wales
Fig. 5.24. One year death rate per 1,000 patient years by UK
country and age group for prevalent dialysis patients, 2013 cohort
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Causes of death
Data completeness
Completeness of cause of death data in the UK
decreased to 64.8% in 2014 from 70.0% in 2013, although
cause of death completeness improved in Northern Ire-
land and Wales (see appendix, table 5.27). Some centres
consistently achieve a very high rate of data return for
cause of death because a process is in place to ensure
that cause of death data was entered. Several centres
have shown substantial improvement in data returns
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Fig. 5.25. Serial one year survival for prevalent dialysis patients by UK country, 2004 to 2013 cohort years, adjusted to age 60
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Fig. 5.26. Relative risk of death in prevalent
RRT patients in the 2013 cohort compared to
the 1998–2001 cohort
Table 5.14. One year survival of prevalent RRT patients in the
UK by age group and diabetic status, 2013 cohort
Patient group Patients Deaths Survival 95% CI
Dialysis patients 2013 cohort
All, age ,65 12,019 975 91.2 90.7–91.8
All, age 65+ 14,165 2,795 79.9 79.3–80.6
Non-diabetic ,65 9,369 592 93.1 92.6–93.6
Non-diabetic 65+ 11,020 2,117 80.5 79.7–81.2
Diabetic ,65 2,650 383 84.8 83.3–86.1
Diabetic 65+ 3,145 678 78.1 76.6–79.5
Cohorts of patients alive on 31/12/2013
Table 5.15. Serial one year survival of prevalent dialysis patients with a primary diagnosis of diabetes, 2004–2013 cohort years
Survival
Year
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
1 year survival % 82.9 82.6 84.9 83.5 83.7 83.2 84.9 85.1 84.6 83.2
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(appendix 1, table 5.27), but there is still much variability
between the centres regarding the completeness of cause
of death with some centres returning no data and other
centres having 100% completeness.
Causes of death in incident RRT patients
The number and proportion of patients with missing
cause of death data in the cohort analysed is shown in
the last row of each table for cause of death (tables 5.17
to 5.21).
Causes of death within the ﬁrst 90 days
See table 5.17.
Causes of death within one year after 90 days
In both the ﬁrst 90 days after start of RRT and the sub-
sequent year, treatment withdrawal as a cause of death
was more common in older patients (aged 65+) whereas
malignancy and cardiac disease were more common in
younger patients (,65 years old) (tables 5.17, 5.18).
Infection as cause of death within the ﬁrst 90 days was
more common in older patients. Cardiac disease
remained the leading cause of death both in the ﬁrst 90
days and one year after the ﬁrst 90 days in both the
older (aged 65+) and younger age groups (aged ,65
years). There has been an increasing trend of treatment
withdrawal as cause of death at 90 days in older patients
Table 5.16. Death rate by age group for prevalent RRT patients, 2013 cohort, compared with the general population and with
previous analyses in the 1998–2001 cohort
Age group
UK
population
mid 2014
(thousands)
UK deaths
in 2014
Death rate
per 1,000
population
Expected
number of
deaths in UKRR
population
UKRR
deaths
in 2014
UKRR death
rate per 1,000
prevalent RRT
patients
Relative risk
of death in
2014
Relative risk
of death
1998–2001
cohort
20–24 4,313 1,605 0.4 0 7 7 19.0 41.1
25–29 4,391 2,037 0.5 1 22 14 30.8 41.8
30–34 4,356 2,762 0.6 1 30 13 20.9 31.2
35–39 3,994 3,756 0.9 3 49 18 18.8 26.0
40–44 4,391 6,327 1.4 6 102 24 16.8 22.6
45–49 4,673 9,758 2.1 12 177 32 15.4 19.0
50–54 4,458 13,876 3.1 19 230 37 11.9 12.8
55–59 3,843 18,897 4.9 30 311 52 10.6 10.1
60–64 3,512 27,708 7.9 45 432 75 9.5 10.4
65–69 3,562 42,444 11.9 72 688 114 9.6 7.9
70–74 2,634 52,572 20.0 97 692 143 7.2 7.2
75–79 2,140 72,014 33.7 139 824 200 5.9 5.3
80–84 1,568 94,419 60.2 157 671 258 4.3 4.0
85+ 1,503 217,023 144.4 178 458 371 2.6 3.0
Total 49,338 565,198 11.5 759 4,693 87 6.2 7.7
Table 5.17. Causes of death in the ﬁrst 90 days for incident patients by age group, 2000–2013 cohort
All age groups ,65 years 565 years
Cause of death N % N % N %
Cardiac disease 785 26 185 29 600 26
Cerebrovascular disease 139 5 31 5 108 5
Infection 527 18 93 14 434 18
Malignancy 274 9 81 12 193 8
Treatment withdrawal 472 16 65 10 407 17
Other 673 22 167 26 506 22
Uncertain 126 4 25 4 101 4
Total 2,996 647 2,349
No cause of death data 2,680 47 589 48 2,091 47
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(aged 65+) over the last four years. Cardiac disease as
cause of death at one year after the ﬁrst 90 days has
decreased over time.
Cause of death in prevalent RRT patients in the 2013
cohort
Table 5.19 shows the cause of death for both prevalent
dialysis and transplant patients in the 2013 cohort. Cardiac
disease as a cause of deathwas less common in transplanted
patients whowere a pre-selected low-risk group of patients.
Malignancy and infection were both responsible for a
greater percentage of deaths in prevalent transplanted
patients, with treatment withdrawal a more common
cause of death in the prevalent dialysis population.
Table 5.20 shows the cause of death for prevalent
dialysis patients in the 2013 cohort.
Table 5.18. Cause of death in one year after 90 days for incident patients by age group, 2000–2013 cohort
All age groups ,65 years 565 years
Cause of death N % N % N %
Cardiac disease 1,234 22 393 25 841 21
Cerebrovascular disease 273 5 82 5 191 5
Infection 1,010 18 280 18 730 18
Malignancy 618 11 202 13 416 10
Treatment withdrawal 929 17 141 9 788 20
Other 1,168 21 359 23 809 20
Uncertain 310 6 88 6 222 6
Total 5,542 1,545 3,997
No cause of death data 4,814 46.5 1,347 46.6 3,467 46.5
Table 5.19. Cause of death in prevalent RRT patients by modality, 2013 cohort
All modalities Dialysis Transplant
Causes of death N % N % N %
Cardiac disease 722 23 628 24 94 18
Cerebrovascular disease 136 4 112 4 24 5
Infection 622 20 498 19 124 24
Malignancy 350 11 214 8 136 26
Treatment withdrawal 504 16 490 19 14 3
Other 607 19 517 20 90 17
Uncertain 189 6 154 6 35 7
Total 3,130 2,613 517
No cause of death data 1,564 33 1,313 33 251 33
Table 5.20. Cause of death in prevalent dialysis patients by age group, 2013 cohort
All age groups ,65 years 565 years
Cause of death N % N % N %
Cardiac disease 628 24 204 31 424 22
Cerebrovascular disease 112 4 42 6 70 4
Infection 498 19 123 19 375 19
Malignancy 214 8 52 8 162 8
Treatment withdrawal 490 19 77 12 413 21
Other 517 20 132 20 385 20
Uncertain 154 6 33 5 121 6
Total 2,613 663 1,950
No cause of death data 1,313 33 353 33 960 0
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Prevalent dialysis patients aged 565 years were sub-
stantially more likely to withdraw from treatment than
younger patients (21% and 12% respectively) and cardiac
disease represented a much higher proportion of all
deaths (amongst those where cause of death was known)
in younger (,65 years) dialysis patients, although the
absolute number of cardiac deaths were higher amongst
those aged 565 years. Figure 5.27 shows cause of death
for prevalent patients in the 2003 to 2013 cohort. Over
time, cardiovascular disease as cause of death has
decreased, treatment withdrawal has increasedwhilst infec-
tion as cause of death remained at a similar level over this
period (ﬁgure 5.27).
Table 5.21 shows that malignancy was a slightly more
common cause of death in younger (,65 years) prevalent
transplanted patients, whereas infection was a more
common cause in older transplanted patients.
Conclusion
Survival of incident patients on RRT at 90 days and
one year after 90 days (adjusted to age 60) increased
slightly in the 2013 cohort compared to the previous
year (2012 cohort). Long term survival of incident
patients on RRT continued to improve over time for one
year up to 10 years post RRT start. Survival increased in
both younger (aged ,65 years) and older patients (aged
565 years) for one year after 90 days survival. This
year’s survival chapter includes a new table (appendix 1,
table 5.25) showing one to ﬁve year survival after the
ﬁrst 90 days of RRT for incident patients by centre,
adjusted for age 60.
There was a difference in short term incident survival
(90 days and one year after 90 days) by age group and
diabetic status: diabetic patients aged ,65 years have
Table 5.21. Cause of death in prevalent transplanted patients by age group, 2013 cohort
All age groups ,65 years 565 years
Cause of death N % N % N %
Cardiac disease 94 18 42 18 52 19
Cerebrovascular disease 24 5 12 5 12 4
Infection 124 24 48 20 76 27
Malignancy 136 26 65 27 71 25
Treatment withdrawal 14 3 7 3 7 3
Other 90 17 47 20 43 15
Uncertain 35 7 17 7 18 6
Total 517 238 279
No cause of death data 251 0 107 0 144 31
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Fig. 5.27. Cause of death in prevalent RRT patients by cohort year
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slightly worse survival than non-diabetic patients, but
survival for older diabetic patients (565 years) was sig-
niﬁcantly better than for non-diabetic patients. This
initial survival difference in older incident patients
diminished over time until there was very little difference
in ﬁve year survival between diabetic and non-diabetic
patients in the older age group (565 years).
One year age adjusted survival for prevalent dialysis
patients declined from 89.3% in the 2012 cohort to
88.6% in the 2013 cohort and prevalent dialysis patient
survival in the UK seems to have peaked in 2010 and
remains relatively stable or slightly lower in more recent
years. The age adjusted one year survival for prevalent
dialysis patients with diabetic primary renal disease in
the UK has been decreasing slightly from 2012 onwards.
The relative one year risk of death on RRT decreased with
age from nearly 19 times that of the general population at
age 35–39 years to 2.6 times at age 85 and over.
In the prevalent RRT dialysis population, cardiovascu-
lar disease was the most common cause of death account-
ing for 24% of deaths, infection accounted for 19% of
deaths and treatment withdrawal for 19% of deaths.
Trends in causes of death over time (2003–2013) show
a decrease in cardiovascular disease, an increase in treat-
ment withdrawal and a plateauing of infection.
Variability in survival between centres was still evi-
dent, with some centres appearing as outliers in the
data (below the lower 95% and above the upper 95% con-
ﬁdence limits) in incident RRT and prevalent dialysis
patient survival. The survival analyses in this chapter
have not been adjusted for any case-mix factors except
for age, and differences in primary renal diagnosis, ethni-
city and comorbidity have not been considered due to
low data completeness in some renal centres. Although
research has suggested that adjustment for comorbidity
only explains a modest part of the variance in ERF patient
outcomes [11], at centre level, the prevalence of comor-
bidities could vary substantially between renal centres
and it would be expected that adjustment for comorbidity
may explain an increased amount of the variance in sur-
vival outcome. The UK Renal Registry regularly evaluates
the effect of adjusting for primary renal diagnosis and
comorbidity in addition to age in those centres returning
585% of comorbidities and repeatedly shows that at
centre level, there is clear beneﬁt for some centres in
adjusting for primary renal diagnosis and comorbidities.
Research using comorbid conditions identiﬁed from hos-
pital episode statistics (HES) data for England RRT
patients showed that adjusting for HES-derived case-
mix, including comorbid conditions, affected the position
and outlying status of some renal centres on the funnel
plot for incident patients and reduced outlying centres
from four to one [10].
Routine linkage of the UK Renal Registry data with
hospital admissions information in the UK will allow
the UKRR to report on survival adjusted for case-mix
(age, ethnicity, primary renal diagnosis and comorbidity)
in future UKRR reports. This will provide a fairer com-
parison between centres and more accurate identiﬁcation
and location of outlying centres on funnel plots.
There is also much variability at centre level in the
hazard of death in the ﬁrst six months from start of
RRT. The proportion of deaths in the ﬁrst 90 days of
starting RRT varies at centre level and in some centres
the proportion is very low or even zero. This may be
due to unreported deaths in patients that die within the
ﬁrst 90 days of starting RRT but may more likely be
due to the exclusion of these patients as acute kidney
injury (AKI) patients. The UKRR will in future be able
to more accurately identify patients with AKI as opposed
to people with chronic kidney disease (CKD) requiring
RRT when data on patients with CKD stage four and
AKI becomes available. This will result in an improve-
ment in the accuracy of survival estimates for patients
starting RRT in the UK.
Conﬂicts of interest: none
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Appendix 1: Survival tables
Table 5.22. One year after 90 day incident survival percentage by centre, 2013 cohort, unadjusted and adjusted to age 60
Centre
Unadjusted
one year after
90 days
survival
Adjusted one
year after
90 days
survival
Adjusted one
year after
90 days 95%
CI
England
B Heart 90.3 93.4 89.2–97.9
B QEH 88.9 91.6 88.3–95.1
Basldn 85.9 90.4 82.9–98.7
Bradfd 94.9 95.4 90.4–100.0
Brightn 82.5 87.1 82.4–92.0
Bristol 87.3 91.2 87.7–94.9
Camb 90.7 93.5 90.0–97.1
Carlis 94.6 95.6 89.9–100.0
Carsh 91.1 94.0 91.3–96.7
Chelms 84.6 92.1 86.2–98.3
Colchr 96.2 97.9 93.9–100.0
Covnt 86.1 90.8 86.1–95.7
Derby 89.0 91.1 85.4–97.1
Donc 88.7 92.2 86.3–98.4
Dorset 89.1 93.2 88.5–98.2
Dudley 90.0 93.7 88.6–99.2
Exeter 91.8 94.9 91.7–98.2
Glouc 94.7 96.7 93.1–100.0
Hull 89.5 91.9 86.9–97.1
Ipswi 82.6 86.7 77.5–97.1
Kent 86.8 90.9 86.9–95.0
L Barts 90.8 91.4 88.1–94.7
L Guys 93.4 94.3 90.5–98.2
L Kings 86.6 90.0 85.9–94.4
L Rfree 89.4 91.6 88.3–95.0
L St.G 89.7 92.2 87.3–97.5
L West 92.4 93.9 91.5–96.4
Leeds 89.0 91.3 87.5–95.2
Leic 87.6 90.7 87.6–93.9
Liv Ain 79.4 85.9 78.2–94.3
Liv Roy 92.9 91.4 85.0–98.1
M RI 88.2 90.2 86.3–94.3
Middlbr 89.2 92.1 87.7–96.7
Newc 90.6 92.8 88.1–97.7
Norwch 82.4 87.7 81.7–94.2
Nottm 90.7 93.2 89.3–97.4
Oxford 91.6 93.6 90.4–96.9
Plymth 90.0 94.4 90.1–98.8
Ports 87.6 91.4 87.8–95.1
Prestn 91.9 93.9 90.5–97.3
Centre
Unadjusted
one year after
90 days
survival
Adjusted one
year after
90 days
survival
Adjusted one
year after
90 days 95%
CI
Redng 90.1 93.1 89.1–97.3
Salford 86.7 89.1 84.1–94.3
Sheff 88.7 91.9 88.0–96.1
Shrew 81.1 86.2 78.3–94.9
Stevng 88.1 90.6 86.6–94.9
Sthend 85.7 89.6 82.2–97.7
Stoke 82.3 88.4 83.1–94.2
Sund 84.0 88.6 81.6–96.3
Truro 92.9 95.4 90.4–100.0
Wirral 89.5 93.4 88.4–98.6
Wolve 85.9 88.8 82.7–95.2
York 83.3 87.5 79.3–96.5
N Ireland
Antrim 88.5 92.4 84.7–100.0
Belfast 89.6 92.1 87.0–97.5
Newry 81.8 84.7 72.3–99.2
Ulster 76.9 88.3 80.1–97.4
West NI 92.4 93.8 86.0–100.0
Scotland
Abrdn 96.1 97.1 93.3–100.0
Airdrie 92.7 95.0 90.4–99.9
Dundee 86.5 90.7 83.5–98.7
Edinb 83.9 81.5 71.9–92.4
Glasgw 87.5 89.8 85.8–93.9
Inverns 95.0 95.0 86.2–100.0
Klmarnk 77.8 83.3 73.4–94.4
Krkcldy 71.4 81.4 71.7–92.4
Wales
Bangor 79.2 89.0 80.5–98.4
Cardff 85.0 89.0 84.9–93.3
Swanse 77.5 84.9 79.4–90.7
Wrexm 80.6 88.2 80.4–96.7
England 89.0 91.8 91.0–92.6
N Ireland 87.0 90.8 87.2–94.5
Scotland 86.8 89.5 87.0–92.0
Wales 81.7 87.6 84.7–90.6
UK 88.4 91.4 90.6–92.2
Excluded: centres with less than 20 patients (Clwyd, D & Gall)
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Table 5.23. Ninety day incident survival percentage by centre, 2013 cohort, unadjusted and adjusted to age 60
Centre
Unadjusted
90 day
survival
Adjusted
90 day
survival
Adjusted
90 day
95% CI
England
B Heart 87.5 93.0 89.2–97.0
B QEH 99.0 99.4 98.5–100.0
Basldn 97.4 98.5 95.8–100.0
Bradfd 96.8 97.3 93.8–100.0
Brightn 94.8 96.9 94.8–99.1
Bristol 97.1 98.3 96.9–99.8
Camb 97.0 98.2 96.5–100.0
Carsh 94.3 96.8 95.0–98.6
Chelms 95.1 98.0 95.3–100.0
Colchr 87.1 93.8 88.1–99.8
Covnt 94.0 96.7 94.2–99.4
Derby 97.3 98.2 95.7–100.0
Donc 86.9 92.6 87.9–97.7
Dorset 95.5 97.7 95.1–100.0
Dudley 98.0 99.0 97.0–100.0
Exeter 94.9 97.4 95.3–99.5
Glouc 96.6 98.2 95.8–100.0
Hull 98.9 99.3 97.8–100.0
Kent 95.9 97.5 95.6–99.5
L Barts 95.3 96.1 94.0–98.2
L Guys 96.9 97.7 95.4–99.9
L Rfree 96.9 97.9 96.4–99.5
L St.G 95.2 96.9 94.0–99.9
L West 98.4 98.9 97.9–99.9
Leeds 93.9 95.9 93.5–98.3
Leic 94.4 96.5 94.7–98.3
Liv Ain 79.4 88.2 82.3–94.6
Liv Roy 89.5 88.8 82.5–95.5
M RI 96.8 97.8 96.0–99.6
Middlbr 92.0 95.0 91.8–98.3
Newc 91.5 94.2 90.4–98.2
Norwch 94.9 97.2 94.5–99.9
Nottm 93.1 95.7 92.9–98.7
Oxford 96.6 97.8 96.1–99.6
Plymth 96.8 98.5 96.5–100.0
Ports 93.1 96.0 93.8–98.3
Centre
Unadjusted
90 day
survival
Adjusted
90 day
survival
Adjusted
90 day
95% CI
Prestn 94.3 96.2 93.8–98.7
Redng 92.9 95.8 93.0–98.7
Salford 97.6 98.3 96.4–100.0
Sheff 94.0 96.5 94.2–99.0
Shrew 88.9 93.5 88.7–98.7
Stevng 95.6 97.1 95.0–99.2
Sthend 97.7 98.7 96.2–100.0
Stoke 87.9 93.3 89.6–97.1
Sund 94.4 96.8 93.2–100.0
Truro 93.6 96.3 92.3–100.0
Wirral 87.9 93.5 89.2–98.0
Wolve 92.9 95.3 91.6–99.0
York 95.6 97.2 93.5–100.0
N Ireland
Antrim 86.7 92.3 85.6–99.6
Belfast 97.5 98.4 96.3–100.0
Newry 95.7 96.8 91.1–100.0
Ulster 83.9 93.3 87.9–99.2
West NI 96.4 97.5 93.0–100.0
Scotland
Abrdn 91.1 94.2 89.4–99.2
Edinb 95.4 95.1 89.9–100.0
Glasgw 97.8 98.5 97.0–100.0
Klmarnk 94.7 96.7 92.4–100.0
Krkcldy 89.7 94.7 89.7–99.9
Wales
Bangor 88.9 95.2 90.2–100.0
Cardff 94.7 96.8 94.7–98.9
Swanse 91.5 95.5 92.7–98.3
Wrexm 95.0 97.4 94.0–100.0
England 95.0 96.9 96.4–97.4
N Ireland 93.2 96.0 93.9–98.2
Scotland 96.4 97.5 96.4–98.7
Wales 93.5 96.5 95.0–97.9
UK 94.9 96.9 96.4–97.4
Excluded: centres with less than 20 patients (Clwyd, D & Gall) and centres with no deaths recorded in the ﬁrst 90 days of RRT (Ipswich, L Kings,
Carlisle, Airdrie, Dundee, Inverness)
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Table 5.24. One year after 90 day incident survival percentage by centre for incident cohort years 2004–2013, adjusted to age 60
Centre 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
England
B Heart 86.5 83.6 88.5 93.5 93.6 83.7 92.0 94.4 86.9 93.4
B QEH 88.0 90.4 86.8 92.8 89.6 92.3 88.3 93.3 92.3 91.6
Basldn 92.4 92.9 90.8 89.9 89.3 86.9 85.7 91.6 89.6 90.4
Bradfd 80.7 86.2 81.3 83.8 84.2 91.6 87.8 88.9 86.7 95.4
Brightn 90.7 84.3 87.0 94.2 89.1 85.6 88.4 91.0 91.1 87.1
Bristol 88.1 82.9 92.4 91.4 84.0 89.2 88.9 94.5 88.1 91.2
Camb 87.0 89.8 90.7 93.4 91.1 87.3 89.5 91.8 92.5 93.5
Carlis 87.0 79.6 89.9 96.5 87.8 71.8 86.3 91.5 95.6
Carsh 85.9 90.6 88.2 87.1 86.6 88.0 89.9 94.3 89.5 94.0
Chelms 82.3 82.9 94.2 86.6 90.8 94.1 85.6 82.1 91.1 92.1
Colchr 85.0 86.3 93.9 84.1 82.6 97.9
Covnt 87.7 82.6 88.5 90.5 86.9 94.2 89.1 90.6 87.9 90.8
Derby 83.1 87.9 93.0 96.4 90.4 88.0 87.4 90.9 89.3 91.1
Donc 89.8 87.8 91.5 90.3 88.9 92.2
Dorset 91.4 82.6 86.2 90.4 93.5 92.4 87.5 88.2 90.2 93.2
Dudley 81.4 97.3 92.6 85.6 71.1 84.1 87.8 93.7 90.0 93.7
Exeter 88.7 86.2 88.7 86.3 87.0 89.1 95.3 88.5 92.9 94.9
Glouc 83.6 95.1 89.6 86.3 94.4 89.2 92.4 89.6 91.3 96.7
Hull 88.9 85.6 93.5 89.6 85.4 89.2 87.9 93.1 90.3 91.9
Ipswi 97.4 84.7 93.8 96.0 95.8 92.2 93.2 95.5 93.1 86.7
Kent 91.8 89.9 89.7 90.5 88.3 94.8 90.9
L Barts 87.1 91.1 93.9 86.4 92.5 90.8 91.7 93.7 90.8 91.4
L Guys 91.6 90.4 92.9 92.0 90.5 94.1 91.5 94.7 94.7 94.3
L Kings 86.9 91.7 84.5 87.5 89.6 85.5 89.7 90.8 89.8 90.0
L Rfree 93.3 89.7 94.4 95.2 89.1 90.3 90.9 93.5 91.6
L St.G 92.1 94.0 92.7 93.7 96.6 93.5 92.2
L West 92.5 94.1 92.8 92.8 94.2 93.1 88.8 90.7 92.5 93.9
Leeds 90.3 89.7 85.0 87.1 88.7 90.4 92.7 88.2 92.5 91.3
Leic 87.5 84.7 87.8 89.8 90.5 90.4 92.0 91.3 90.3 90.7
Liv Ain 86.9 82.8 78.5 82.7 89.0 86.3 95.1 85.9
Liv Roy 80.8 90.0 86.4 86.2 94.1 93.9 88.5 88.9 89.9 91.4
M RI 90.1 87.7 87.5 89.6 93.2 89.9 90.2
Middlbr 85.4 82.8 91.5 87.9 82.3 86.8 88.0 88.9 89.6 92.1
Newc 85.4 82.1 86.2 85.8 91.3 85.7 88.8 86.0 85.7 92.8
Norwch 84.7 90.7 86.4 91.0 89.0 89.7 92.2 89.5 88.2 87.7
Nottm 85.7 87.0 91.9 90.0 91.1 88.8 93.5 92.7 90.0 93.2
Oxford 87.9 87.9 89.9 89.2 87.1 91.6 90.6 88.8 93.9 93.6
Plymth 77.9 84.6 81.0 90.1 87.8 89.0 93.8 91.3 92.0 94.4
Ports 88.4 83.2 87.5 88.7 88.8 90.1 88.1 91.2 91.0 91.4
Prestn 87.4 88.5 83.6 91.4 82.1 87.5 87.6 91.8 92.8 93.9
Redng 91.0 89.7 91.3 90.1 95.3 89.0 93.0 93.0 96.0 93.1
Salford 84.8 88.3 90.5 89.2 86.0 89.1 86.4 91.9 89.0 89.1
Sheff 91.5 90.6 88.6 90.9 92.5 94.1 92.2 87.5 93.4 91.9
Shrew 87.5 86.2 87.7 91.8 92.9 84.7 86.9 91.7 85.0 86.2
Stevng 93.3 76.7 85.3 90.7 90.2 96.7 94.0 91.1 93.1 90.6
Sthend 90.5 91.1 94.8 91.8 86.2 91.5 82.0 94.3 89.6
Stoke 87.1 89.7 85.8 87.1 93.0 94.0 88.4
Sund 86.8 80.6 83.5 88.7 85.3 83.0 84.1 88.7 93.0 88.6
Truro 92.8 90.6 89.4 90.2 89.2 94.2 90.9 93.3 94.6 95.4
Wirral 85.4 87.0 85.9 88.9 90.4 84.8 93.0 86.7 86.1 93.4
Wolve 88.1 84.2 89.2 89.5 89.3 88.5 87.5 89.4 84.1 88.8
York 91.4 83.9 82.6 95.1 86.2 94.1 86.3 93.4 93.9 87.5
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Table 5.24. Continued
Centre 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
N Ireland
Antrim 85.0 93.9 85.2 88.6 97.4 85.9 85.9 86.6 92.4
Belfast 85.1 92.4 90.8 88.0 91.4 88.3 92.5 93.0 92.1
Newry 90.2 92.0 85.4 89.8 84.7
Ulster 90.9 86.3 88.3
West NI 90.1 97.3 93.1 97.6 91.4 95.8 93.8
Scotland
Abrdn 88.8 84.2 84.6 86.0 86.9 88.8 85.4 92.8 91.5 97.1
Airdrie 86.2 75.1 80.7 76.7 88.3 94.2 82.1 84.0 92.0 95.0
D & Gall 84.0
Dundee 80.5 84.4 89.2 82.4 85.2 87.7 90.2 90.5 93.4 90.7
Edinb 75.9 83.3 88.6 90.2 84.1 84.7 86.4 89.7 92.9 81.5
Glasgw 80.5 86.1 83.6 87.8 83.2 88.4 86.8 88.6 90.1 89.8
Inverns 89.3 84.3 83.8 90.6 87.1 96.7 95.0
Klmarnk 87.4 96.3 82.7 86.7 90.1 84.0 88.4 91.0 90.9 83.3
Krkcldy 80.5 78.3 80.1 87.4 86.6 90.7 93.6 92.4 97.3 81.4
Wales
Bangor 81.0 82.3 81.4 92.2 87.8 87.3 89.1 94.3 89.0
Cardff 85.5 87.2 87.0 84.2 83.2 89.3 90.0 88.1 86.8 89.0
Clwyd 75.5 96.9 92.3
Swanse 77.8 82.7 84.1 89.0 85.1 81.7 86.8 85.0 83.8 84.9
Wrexm 77.3 97.7 85.5 89.9 82.1 88.8 86.0 88.2
England 87.9 87.9 88.9 90.2 89.5 89.8 89.9 91.1 91.2 91.8
N Ireland 87.7 91.1 90.2 87.8 92.1 89.2 89.9 93.0 90.8
Scotland 83.0 84.5 84.7 86.5 85.5 87.2 87.8 90.1 91.6 89.5
Wales 82.6 86.0 86.1 86.7 84.4 87.3 88.8 87.6 85.4 87.6
UK 87.0 87.4 88.4 89.6 88.9 89.5 89.7 90.8 91.0 91.4
Blank cells: centres with either less than 20 patients, no deaths or no data contribution to the UKRR for that year
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Table 5.25. Incident survival percentage after 90 days from start of RRT by centre for incident cohort years 2009–2013, adjusted to
age 60
Centre
5 year survival
2009 cohort
4 year survival
2010 cohort
3 year survival
2011 cohort
2 year survival
2012 cohort
1 year survival
2013 cohort
England
B Heart 49.3 63.1 79.1 82.4 93.4
B QEH 68.3 70.1 80.5 86.1 91.6
Basldn 57.5 69.1 82.8 81.0 90.4
Bradfd 60.0 67.4 70.8 82.1 95.4
Brightn 59.9 67.9 76.8 85.3 87.1
Bristol 58.6 69.0 82.7 81.8 91.2
Camb 66.4 69.7 77.9 84.3 93.5
Carlis 47.4 71.7 73.4 95.6
Carsh 64.9 69.1 82.5 82.4 94.0
Chelms 68.4 72.8 71.0 87.6 92.1
Colchr 65.3 71.7 68.9 70.4 97.9
Covnt 71.3 68.5 77.6 81.1 90.8
Derby 63.1 60.4 73.6 79.0 91.1
Donc 53.1 61.2 77.8 84.6 92.2
Dorset 63.6 61.1 76.2 83.7 93.2
Dudley 43.3 65.0 83.5 78.7 93.7
Exeter 56.2 72.8 72.0 87.7 94.9
Glouc 65.0 72.4 77.2 82.8 96.7
Hull 61.3 62.7 78.7 83.0 91.9
Ipswi 61.3 74.0 80.7 85.8 86.7
Kent 61.8 68.8 75.2 87.6 90.9
L Barts 65.4 73.4 79.4 83.2 91.4
L Guys 63.0 72.8 84.3 85.4 94.3
L Kings 56.4 72.7 80.3 80.6 90.0
L Rfree 62.5 69.8 78.3 88.5 91.6
L St.G 61.1 76.9 84.5 87.3 92.2
L West 64.4 72.3 78.4 83.9 93.9
Leeds 55.0 65.4 72.3 86.2 91.3
Leic 62.8 75.7 75.9 83.9 90.7
Liv Ain 57.7 47.1 66.5 85.3 85.9
Liv Roy 58.1 70.5 63.7 80.8 91.4
M RI 56.2 61.3 73.5 79.9 90.2
Middlbr 60.4 74.3 73.7 82.2 92.1
Newc 50.4 60.6 77.4 80.4 92.8
Norwch 64.8 69.7 76.1 83.3 87.7
Nottm 57.5 70.2 82.4 85.0 93.2
Oxford 66.3 66.7 74.2 87.7 93.6
Plymth 62.8 61.1 78.5 84.4 94.4
Ports 61.2 66.9 72.8 81.3 91.4
Prestn 57.1 60.3 78.5 85.7 93.9
Redng 62.2 73.2 79.3 88.9 93.1
Salford 49.1 59.5 77.6 79.9 89.1
Sheff 61.2 75.0 73.4 87.1 91.9
Shrew 53.5 56.8 72.7 77.2 86.2
Stevng 66.1 71.8 79.0 88.2 90.6
Sthend 74.7 71.7 82.0 86.3 89.6
Stoke 59.7 64.7 71.6 89.0 88.4
Sund 50.5 64.2 65.4 86.7 88.6
Truro 59.0 65.5 81.3 90.6 95.4
Wirral 54.0 73.9 75.9 78.4 93.4
Wolve 45.5 64.0 70.9 78.1 88.8
York 69.2 63.9 81.3 87.4 87.5
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Table 5.25. Continued
Centre
5 year survival
2009 cohort
4 year survival
2010 cohort
3 year survival
2011 cohort
2 year survival
2012 cohort
1 year survival
2013 cohort
N Ireland
Antrim 46.7 51.6 76.0 86.4 92.4
Belfast 55.1 57.8 72.8 78.8 92.1
Newry 63.5 81.8 84.7
Ulster 80.0 88.3
West NI 68.4 64.0 84.1 94.7 93.8
Scotland
Abrdn 57.0 63.4 74.7 87.8 97.1
Airdrie 66.0 53.2 71.7 76.7 95.0
D & Gall 57.5
Dundee 56.1 69.2 76.6 87.9 90.7
Edinb 50.7 64.6 75.3 87.9 81.5
Glasgw 49.2 61.9 66.3 83.2 89.8
Inverns 77.9 95.0
Klmarnk 47.8 59.4 60.2 80.5 83.3
Krkcldy 62.5 66.1 59.9 80.0 81.4
Wales 64.5
Bangor 65.0 59.4 64.7 89.0
Cardff 53.6 69.7 70.8 79.9 89.0
Clwyd 69.3 48.7
Swanse 54.2 60.6 70.5 76.0 84.9
Wrexm 65.0 72.4 69.0 88.2
England 60.8 68.8 77.0 84.0 91.8
N Ireland 56.8 63.8 75.2 85.0 90.8
Scotland 52.8 62.9 70.4 83.7 89.5
Wales 55.3 64.5 69.9 77.1 87.6
UK 59.9 67.9 76.0 83.6 91.4
Blank cells: centres with less than 20 patients for that year
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Table 5.26. One year prevalent patient survival percentage by centre for prevalent cohort years 2004–2013, adjusted to age 60
Centre 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
England
B Heart 87.9 86.6 87.8 90.4 90.9 87.4 89.5 88.4 89.1 87.5
B QEH 89.0 88.2 88.0 88.3 89.9 89.3 91.0 91.5 91.8 89.6
Basldn 90.1 89.9 90.3 92.6 91.6 88.5 90.8 88.4 92.7 86.4
Bradfd 86.4 82.9 84.3 87.7 84.5 89.2 88.0 87.7 85.1 87.5
Brightn 84.4 87.6 87.2 88.7 87.4 89.9 88.2 89.4 88.3 87.2
Bristol 87.4 87.7 89.2 87.4 85.0 85.8 89.7 90.8 90.0 89.2
Camb 87.2 89.3 88.0 92.6 90.0 91.4 93.1 89.1 92.8 87.7
Carlis 83.7 83.9 85.8 87.0 80.3 80.5 93.2 88.9 82.9 88.3
Carsh 85.7 89.2 88.4 89.8 88.7 89.2 89.6 91.0 90.5 89.6
Chelms 82.9 85.6 87.5 85.1 86.1 89.6 84.1 91.6 90.7 90.5
Colchr 91.1 86.6 89.0 89.2 85.9 88.4
Covnt 89.3 84.8 87.2 87.3 90.9 90.2 91.0 91.9 90.6 86.1
Derby 87.4 88.5 86.9 90.3 90.4 90.0 89.8 89.8 88.2 90.1
Donc 88.8 83.9 88.9 91.8 91.5 82.8 90.4
Dorset 89.4 87.0 87.5 89.9 90.1 93.0 90.0 90.5 91.9 92.2
Dudley 85.9 87.3 87.2 88.8 88.8 90.8 87.7 91.5 86.8 87.4
Exeter 84.0 91.1 87.4 85.6 85.5 86.7 88.4 88.3 91.7 90.1
Glouc 88.2 91.1 88.2 86.3 91.7 92.1 89.5 90.7 89.7 92.1
Hull 84.3 85.8 89.9 86.7 87.7 87.5 89.8 90.9 88.5 87.6
Ipswi 85.6 84.2 86.1 93.1 84.4 87.5 91.8 90.3 88.0 89.6
Kent 86.3 87.9 90.4 89.7 89.1 87.8 87.8
L Barts 85.6 88.3 89.3 88.7 90.8 92.9 91.7 89.8 91.2 90.3
L Guys 89.3 87.3 90.5 90.3 91.4 91.0 93.9 91.2 90.9 90.5
L Kings 86.4 88.6 84.3 87.4 87.6 88.8 89.7 89.4 88.9 90.4
L Rfree 90.0 90.3 91.2 89.7 90.3 91.6 90.2 90.9 90.0
L St.G 94.3 89.2 90.8 91.9 88.4 91.7 92.2
L West 91.2 91.2 91.5 90.3 92.0 90.6 90.6 91.7 90.2 90.0
Leeds 88.9 88.4 88.2 87.3 88.8 90.8 88.9 86.6 88.3 88.7
Leic 86.6 84.4 89.7 89.5 88.6 90.4 89.8 90.3 89.0 89.3
Liv Ain 97.0 86.8 90.5 88.3 91.9 89.7 89.7 83.8 84.2 87.6
Liv Roy 83.6 87.6 84.4 86.4 89.1 88.9 90.5 88.5 87.8 87.0
M RI 86.3 87.6 86.9 88.5 90.7 86.1 86.3
Middlbr 86.0 85.0 87.1 86.8 86.4 83.3 93.0 88.5 88.7 85.3
Newc 85.9 83.7 86.0 86.3 87.0 86.1 85.0 89.2 84.4 86.4
Norwch 88.4 90.3 87.6 91.1 89.6 89.9 91.3 91.4 88.6 88.8
Nottm 84.8 83.2 89.5 88.3 88.0 89.6 89.9 88.9 90.5 88.5
Oxford 87.2 86.7 86.7 87.7 88.3 87.1 87.8 88.0 89.4 87.5
Plymth 87.8 83.8 82.8 88.1 85.9 85.3 89.9 84.8 89.9 86.9
Ports 86.0 85.2 89.8 88.5 89.2 88.4 88.3 90.0 90.3 85.7
Prestn 85.8 86.3 90.8 90.2 89.7 90.1 88.2 90.6 89.1 88.7
Redng 86.3 89.0 90.3 88.9 92.4 88.9 89.4 90.9 90.9 89.5
Salford 82.6 85.3 87.6 86.0 87.5 84.6 87.0 88.4 87.5 89.0
Sheff 86.9 89.2 88.8 88.8 89.7 89.6 88.7 89.0 91.4 88.2
Shrew 86.3 86.6 89.1 89.0 87.9 85.6 87.4 89.9 83.9 86.4
Stevng 88.8 89.4 89.8 92.5 90.5 90.0 92.8 92.1 89.1 92.0
Sthend 87.0 83.4 86.3 90.2 91.0 92.4 90.3 87.8 91.8 90.3
Stoke 87.4 88.4 86.9 90.6 90.5 91.6 88.8
Sund 86.4 79.4 83.7 87.5 85.3 84.8 83.8 86.6 84.9 88.1
Truro 84.9 91.8 89.3 89.5 89.0 90.7 89.1 89.7 88.9 90.1
Wirral 89.4 88.4 88.1 89.3 90.3 88.6 90.7 90.2 90.8 84.5
Wolve 86.5 89.3 87.9 92.6 89.5 87.4 89.3 88.8 89.0 89.9
York 89.4 84.0 88.5 87.8 88.9 90.0 84.2 88.7 91.5 88.2
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Table 5.26. Continued
Centre 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
N Ireland
Antrim 85.2 85.2 87.8 89.5 88.1 91.6 90.0 90.5 85.3
Belfast 89.5 89.5 87.8 87.0 87.4 87.3 87.7 85.2 89.2
Newry 87.3 87.3 89.1 91.5 86.6 91.1 81.5 90.0 90.6
Ulster 89.5 89.5 89.6 87.4 89.8 89.0 90.9 91.2 91.3
West NI 90.2 90.2 92.7 89.3 91.0 90.7 91.4 91.7 85.6
Scotland
Abrdn 87.2 86.1 87.1 89.4 89.3 89.6 89.0 91.2 88.5 84.1
Airdrie 82.8 79.7 79.4 86.0 85.5 89.4 88.4 86.4 85.8 85.7
D & Gall 91.7 81.3 90.2 83.9 86.5 86.4 90.6 86.5 89.8 86.4
Dundee 86.4 86.6 82.6 82.6 93.0 86.9 86.9 91.1 88.5 90.4
Edinb 84.5 85.7 87.0 87.5 85.7 88.4 81.2 89.2 88.9 87.4
Glasgw 86.7 85.7 87.5 87.7 87.8 87.9 87.3 87.5 87.1 87.8
Inverns 85.5 85.6 93.4 88.6 91.7 88.3 85.9 87.1 86.3 88.7
Klmarnk 84.1 91.9 87.0 89.0 88.1 88.1 88.8 89.5 86.9 91.7
Krkcldy 89.0 87.4 87.6 89.9 85.0 86.2 89.0 86.9 90.5 84.2
Wales
Bangor 86.6 88.5 81.5 88.7 85.1 85.5 86.9 89.9 84.5 85.6
Cardff 84.4 84.1 88.8 82.5 86.5 85.8 88.3 86.3 87.6 86.6
Clwyd 82.0 77.3 90.5 87.1 88.8 78.2 93.1 90.0 86.3 88.8
Swanse 89.0 85.4 88.0 89.4 87.3 87.4 89.0 86.2 88.4 87.2
Wrexm 82.1 85.1 87.6 85.1 89.0 86.7 85.8 87.3 89.3 88.0
England 87.8 88.3 88.5 88.9 89.0 89.2 89.9 89.9 89.5 88.8
N Ireland 87.3 88.4 89.0 88.6 88.5 89.6 88.6 89.1 88.3
Scotland 86.1 85.7 86.6 87.3 88.0 88.0 87.0 88.5 87.7 87.3
Wales 85.6 84.6 87.9 85.5 86.9 85.9 88.5 86.8 87.6 86.9
UK 87.5 87.8 88.3 88.6 88.8 88.9 89.6 89.6 89.3 88.6
Blank cells: data not reported to the UKRR for that year or less than 20 patients in the year
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Table 5.27. Percentage completeness of EDTA cause of death for prevalent patients by centre and year of death, 2005 to 2014
Centre 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
England
B Heart 68.1 85.7 84.5 93.9 100.0 96.6 96.1 96.6 95.0 65.6
B QEH 60.0 4.7 7.0 5.8 0.7 1.7 2.0 2.1 61.9 90.4
Basldn 45.0 21.7 45.5 47.6 76.2 66.7 84.6 88.9 90.9 90.0
Bradfd 87.8 92.2 86.5 92.5 81.8 97.0 97.5 97.7 97.9 98.0
Brightn 0.0 0.0 11.9 0.0 1.1 2.4 1.1 1.1 0.0 0.9
Bristol 76.9 61.0 60.3 66.4 70.7 89.4 96.1 82.2 82.0 90.0
Camb 1.5 1.3 1.1 1.6 5.1 10.4 62.0 94.1 80.5 42.3
Carlis 91.3 91.3 73.9 47.6 80.6 100.0 92.9 94.7 92.3 92.0
Carsh 0.0 0.0 0.8 1.5 0.8 6.7 25.0 40.8 17.4 16.3
Chelms 68.6 64.0 76.5 71.4 86.7 86.7 87.0 96.3 92.3 85.7
Colchr 33.3 66.7 85.2 82.6 100.0 91.7 77.3
Covnt 0.0 0.0 0.0 1.2 1.8 0.0 1.4 33.3 70.5 6.7
Derby 77.6 75.6 83.3 97.8 73.5 91.2 88.5 86.9 88.7 73.7
Donc 100.0 94.3 90.9 91.7 92.6 100.0 96.8
Dorset 61.5 65.1 87.2 88.9 85.2 95.7 95.0 89.1 98.3 90.6
Dudley 14.3 5.9 6.1 5.3 0.0 94.4 88.1 91.2 94.0 95.5
Exeter 36.7 19.0 4.7 3.1 3.0 89.5 84.6 95.1 98.6 96.5
Glouc 64.5 61.1 77.8 70.8 68.4 97.2 93.6 91.5 100.0 88.1
Hull 81.5 76.0 76.5 52.7 18.7 92.0 93.5 96.9 86.8 91.7
Ipswi 10.3 21.9 35.5 13.6 18.8 73.3 77.8 77.4 78.8 83.3
Kent 61.7 92.8 89.0 96.2 94.9 81.4 86.6
L Barts 83.3 87.4 74.6 77.0 69.5 73.9 82.6 79.9 82.9 82.7
L Guys 0.0 0.0 3.5 0.0 0.0 67.6 84.2 58.2 1.1 0.0
L Kings 85.7 87.9 75.8 86.2 67.1 94.8 97.6 100.0 98.9 98.7
L Rfree 0.0 0.0 0.0 0.9 1.7 0.0 7.1 5.7 15.9
L St.G 16.7 17.9 21.4 77.6 47.9 42.4 62.5 57.1
L West 79.8 31.3 18.9 6.3 2.2 2.2 95.0 97.3 96.4 93.8
Leeds 69.3 66.7 29.6 30.1 34.5 100.0 99.1 97.7 98.3 99.2
Leic 72.5 76.9 65.5 69.5 69.8 74.5 61.7 94.1 80.0 55.2
Liv Ain 50.0 81.3 73.3 66.7 100.0 85.0 95.7 0.0 0.0 0.0
Liv Roy 41.5 66.3 76.8 75.8 82.1 71.6 76.4 2.8 33.7 19.0
M RI 4.0 0.9 1.0 4.7 3.1 10.0 0.8 1.4
Middlbr 79.4 63.5 57.5 26.0 52.0 89.2 97.5 94.9 81.3 95.1
Newc 20.8 29.8 48.7 35.7 40.8 14.0 45.0 16.9 23.6 51.8
Norwch 21.0 21.4 18.2 21.2 44.4 75.8 70.3 76.5 91.0 74.0
Nottm 97.0 87.5 87.0 98.8 97.1 98.8 100.0 100.0 97.6 98.9
Oxford 2.8 0.0 0.0 1.0 0.0 84.6 97.4 92.7 96.5 98.3
Plymth 51.4 45.8 56.7 70.7 47.5 80.9 43.6 41.2 100.0 24.5
Ports 21.5 12.8 21.4 6.9 44.5 68.7 23.3 19.8 40.7 38.8
Prestn 50.0 55.4 47.8 38.1 17.9 95.7 98.9 96.4 99.0 95.2
Redng 81.5 77.1 97.8 89.6 83.0 100.0 96.7 91.2 91.9 79.7
Salford 0.0 0.0 1.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0
Sheff 4.6 9.2 12.9 0.9 1.9 3.0 0.8 0.8 1.9 0.9
Shrew 66.7 53.1 89.3 62.5 20.5 46.0 0.0 7.9 17.7 0.0
Stevng 86.3 60.8 55.1 67.2 74.3 86.3 86.8 67.7 69.8 9.3
Sthend 39.4 9.4 3.2 57.7 75.0 92.3 90.0 100.0 100.0 95.7
Stoke 16.1 21.0 28.6 54.7 57.9 89.6 55.0 53.5
Sund 56.3 60.0 60.5 50.0 78.9 93.5 95.1 97.4 82.6 97.4
Truro 2.3 6.9 0.0 18.4 28.9 93.3 94.9 78.8 100.0 97.1
Wirral 31.3 94.1 84.6 96.9 84.8 86.5 0.0 2.6 25.8 68.5
Wolve 92.3 47.8 51.5 65.8 76.4 98.4 94.1 92.2 83.8 85.2
York 41.4 83.3 38.5 62.1 67.9 96.7 97.3 100.0 100.0 97.4
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Table 5.27. Continued
Centre 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
N Ireland
Antrim 4.0 10.0 8.6 3.4 26.9 96.8 95.2 100.0 93.1 100.0
Belfast 17.2 33.8 36.0 20.0 25.4 81.7 75.9 77.0 41.7 51.1
Newry 0.0 42.9 15.0 11.8 68.4 95.2 94.4 96.7 100.0 93.3
Ulster 100.0 85.7 92.9 69.2 75.0 95.0 90.9 100.0 95.7 90.0
West NI 40.0 57.7 35.0 22.2 45.8 92.3 80.0 96.6 96.2 93.9
Scotland
Abrdn 2.8 0.0 2.1 100.0 100.0 100.0 100.0 97.1 90.7 67.7
Airdrie 40.0 26.3 100.0 100.0 100.0 100.0 97.0 93.9 100.0 97.6
D & Gall 80.0 76.9 100.0 93.3 94.4 100.0 100.0 87.5 100.0 100.0
Dundee 88.9 2.8 9.3 100.0 96.9 100.0 100.0 100.0 100.0 52.8
Edinb 52.5 29.3 48.3 100.0 97.5 100.0 98.8 100.0 96.4 96.2
Glasgw 45.9 55.1 59.1 100.0 97.8 97.1 99.3 99.2 98.7 100.0
Inverns 0.0 0.0 0.0 100.0 94.7 100.0 100.0 100.0 100.0 100.0
Klmarnk 0.0 11.1 15.6 100.0 96.7 97.0 100.0 100.0 100.0 100.0
Krkcldy 88.2 65.0 61.5 100.0 96.4 96.6 100.0 96.9 100.0 92.3
Wales
Bangor 66.7 35.0 86.2 52.4 76.9 73.9 90.0 100.0 95.8 95.0
Cardff 4.3 2.9 4.9 0.0 2.4 6.7 7.9 0.6 73.5 96.7
Clwyd 5.9 11.1 45.5 84.2 83.3 100.0 85.7 89.5 83.3 90.0
Swanse 85.7 92.4 97.3 94.8 89.8 98.0 87.5 98.1 95.7 82.6
Wrexm 3.6 3.4 22.7 69.2 100.0 95.7 92.6 100.0 95.7 87.0
England 47.7 41.5 37.9 36.9 39.0 58.8 63.5 64.4 64.7 60.1
N Ireland 19.5 38.7 31.7 20.4 40.8 89.9 84.0 90.7 75.2 81.5
Scotland 43.2 33.7 44.9 99.8 97.6 98.6 99.3 98.2 98.2 89.7
Wales 29.3 30.7 43.8 36.3 47.6 53.3 48.6 50.5 84.8 91.2
UK 45.2 39.9 38.7 42.2 44.9 62.9 66.6 67.1 69.0 64.8
Blank cells: data not available for that year
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